Delving into the Latest Updates on Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd. with Synapse

Overview

Tags

Other Diseases

Neoplasms

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	2

Top 5 Target	Count

GLUT2 x SGLT2	1

主要目的：评价注射用 GMDTC 给药后在镉超标人群中的药效动力学特征；次要目的：评价注射用 GMDTC 在镉超标人群中多次给药的安全性、耐受性及药代动力学特征；探索性目的：评价与安慰剂相比，注射用 GMDTC 在镉超标人群中肾脏功能早期损伤的改善。

[Translation]

Primary objective: To evaluate the pharmacodynamic characteristics of GMDTC for injection in people with excessive cadmium levels after administration; Secondary objective: To evaluate the safety, tolerability and pharmacokinetic characteristics of GMDTC for injection after multiple administration in people with excessive cadmium levels; Exploratory objective: To evaluate the improvement of early renal function damage in people with excessive cadmium levels by GMDTC for injection compared with placebo.

Start Date07 Jul 2025

Sponsor / Collaborator

Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.

NCT06199349

/ CompletedPhase 1

Phase Ib Clinical Study on the Safety, Tolerability and Pharmacokinetic Characteristics of GMDTC for Injection After Repeated Administration in People With Excessive Cadmium Levels

This trial is a randomized, double-blind, single-center, single-dose escalating Phase I clinical trial designed to evaluate the safety, tolerability, and pharmacokinetic characteristics of GMDTC for injection after repeated administration in people with excessive cadmium levels.

Start Date08 Jan 2024

Sponsor / Collaborator

Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.

CTR20234320

/ CompletedPhase 1

注射用GMDTC在镉超标人群中多次给药的安全性、耐受性和药代动力学特征Ⅰb期临床研究

[Translation] Phase Ib clinical study on the safety, tolerability and pharmacokinetic characteristics of multiple administrations of GMDTC for injection in people with excessive cadmium levels

主要目的：评价注射用GMDTC在镉超标人群中多次给药的安全性和耐受性；次要目的：评价注射用GMDTC在镉超标人群中多次给药的药代动力学特征和药效动力学特征。

[Translation]

Primary purpose: To evaluate the safety and tolerability of multiple administrations of GMDTC for injection in people with excessive cadmium levels; Secondary purpose: To evaluate the pharmacokinetic and pharmacodynamic characteristics of multiple administrations of GMDTC for injection in people with excessive cadmium levels.

Start Date08 Jan 2024

Sponsor / Collaborator

Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.

100 Clinical Results associated with Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Deals associated with Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 15 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

1

Phase 2

Login to view more data